Bain Capital Life Sciences Investors, LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$1.3T
Holdings
34
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,831,307 | $299.4B | 23.75% | |
| 2 | DVAXDYNAVAX TECHNOLOGIES CORP | 8,415,000 | $118.4B | 9.39% | |
| 3 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $89.7B | 7.12% | |
| 4 | ARQTARCUTIS BIOTHERAPEUTICS INC | 3,979,292 | $82.5B | 6.55% | |
| 5 | —EQRX INC | 10,003,573 | $68.2B | 5.41% | |
| 6 | NUVLNUVALENT INC | 3,428,014 | $65.3B | 5.18% | |
| 7 | CRNXCRINETICS PHARMACEUTICALS IN | 2,029,701 | $57.7B | 4.57% | |
| 8 | CCCCC4 THERAPEUTICS INC | 1,642,210 | $52.9B | 4.19% | |
| 9 | PHVSPHARVARIS N V | 3,180,601 | $45.8B | 3.63% | |
| 10 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $44.9B | 3.56% | |
| 11 | ANNXANNEXON INC | 3,241,628 | $37.2B | 2.95% | |
| 12 | NRIXNURIX THERAPEUTICS INC | 1,284,313 | $37.2B | 2.95% | |
| 13 | —MERSANA THERAPEUTICS INC | 5,385,667 | $33.5B | 2.66% | |
| 14 | —APTINYX INC | 8,891,758 | $23.7B | 1.88% | |
| 15 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $22.2B | 1.76% | |
| 16 | TNGXTANGO THERAPEUTICS INC | 1,921,790 | $21.0B | 1.67% | |
| 17 | —SYROS PHARMACEUTICALS INC | 6,264,420 | $20.4B | 1.62% | |
| 18 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $17.0B | 1.35% | |
| 19 | YB4PSAVARA INC | 11,622,598 | $14.4B | 1.14% | |
| 20 | IVVDADAGIO THERAPEUTICS INC | 1,937,207 | $14.1B | 1.12% | |
| 21 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $13.9B | 1.10% | |
| 22 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,847,689 | $13.5B | 1.07% | |
| 23 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $10.4B | 0.82% | |
| 24 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $9.8B | 0.77% | |
| 25 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $6.9B | 0.55% | |
| 26 | ASNSUSDX4 PHARMACEUTICALS INC | 2,886,542 | $6.6B | 0.52% | |
| 27 | —BLUEBIRD BIO INC | 538,179 | $5.4B | 0.43% | |
| 28 | —ARYA SCIENCES ACQUISITN CORP | 500,000 | $4.8B | 0.38% | |
| 29 | —PANACEA ACQUISITION CORP II | 500,000 | $4.8B | 0.38% | |
| 30 | —BCLS ACQUISITION CORP | 487,500 | $4.8B | 0.38% | |
| 31 | TSVT*2SEVENTY BIO INC | 179,393 | $4.6B | 0.36% | |
| 32 | —OMEGA ALPHA SPAC | 400,000 | $3.9B | 0.31% | |
| 33 | —FRAZIER LIFESCIENCES ACQU CO | 300,000 | $3.0B | 0.24% | |
| 34 | —JIYA ACQUISITION CORP | 300,000 | $2.9B | 0.23% |